• Profile
Close

New blood test to detect silent, lethal pancreatic cancer

IANS Nov 21, 2023

Researchers have developed a novel blood test that could lead to the first early detection of pancreatic cancer.


Pancreatic cancer has a poor survival rate marred by a lack of distinct symptoms and screening tools needed to detect the disease in its initial stages.

The team from Walter and Eliza Hall Institute of Medical Research (WEHI) in Australia hopes that the test will, for the first time, accurately identify patients with early stages of pancreatic cancer – a crucial step towards improving survival rates and quality of life for patients.

“There are no early detection biomarkers for pancreatic cancer and this needs to urgently change,” said Dr Belinda Lee, a consultant medical oncologist at WEHI.

The team identified 13 proteins that could distinguish between the early and late stages of pancreatic ductal adenocarcinoma (PDAC) -- the most common type of pancreatic cancer that’s fast becoming the cancer of our generation.

“We hope to validate these proteins and show that they can be used to reliably screen for early pancreatic cancer," Lee said.

“This would allow us to create the first diagnostic test to identify patients who have early stages of pancreatic cancer -- something that unfortunately does not exist at the moment," she added.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay